These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31272074)

  • 1. miR-340-5p Suppresses Aggressiveness in Glioblastoma Multiforme by Targeting Bcl-w and Sox2.
    Kim S; Choi JY; Seok HJ; Park MJ; Chung HY; Bae IH
    Mol Ther Nucleic Acids; 2019 Sep; 17():245-255. PubMed ID: 31272074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylation of miR-205-5p by IR Governs Aggressiveness and Metastasis via Regulating Bcl-w and Src.
    Kim ES; Choi JY; Hwang SJ; Bae IH
    Mol Ther Nucleic Acids; 2019 Mar; 14():450-464. PubMed ID: 30743214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM.
    Yue S; Wang L; Zhang H; Min Y; Lou Y; Sun H; Jiang Y; Zhang W; Liang A; Guo Y; Chen P; Lv G; Wang L; Zong Q; Li Y
    Tumour Biol; 2015 Sep; 36(9):6741-9. PubMed ID: 25833697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-w Enhances Mesenchymal Changes and Invasiveness of Glioblastoma Cells by Inducing Nuclear Accumulation of β-Catenin.
    Lee WS; Woo EY; Kwon J; Park MJ; Lee JS; Han YH; Bae IH
    PLoS One; 2013; 8(6):e68030. PubMed ID: 23826359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-425-5p, a SOX2 target, regulates the expression of FOXJ3 and RAB31 and promotes the survival of GSCs.
    de la Rocha AMA; González-Huarriz M; Guruceaga E; Mihelson N; Tejada-Solís S; Díez-Valle R; Martínez-Vélez N; Fueyo J; Gomez-Manzano C; Alonso MM; Laterra J; López-Bertoni H
    Arch Clin Biomed Res; 2020; 4(3):221-238. PubMed ID: 32905473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-429 suppresses glioblastoma multiforme by targeting SOX2.
    Dong H; Hao X; Cui B; Guo M
    Cell Biochem Funct; 2017 Jul; 35(5):260-268. PubMed ID: 28749077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-744-5p inhibits glioblastoma malignancy by suppressing replication factor C subunit 2.
    Fan F; Yao D; Yan P; Jiang X; Hu J
    Oncol Lett; 2021 Aug; 22(2):608. PubMed ID: 34188710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme.
    Ho KH; Cheng CH; Chou CM; Chen PH; Liu AJ; Lin CW; Shih CM; Chen KC
    Pharmacol Res; 2019 Sep; 147():104390. PubMed ID: 31398406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.
    Liu J; Jiang J; Hui X; Wang W; Fang D; Ding L
    Cell Physiol Biochem; 2018; 48(5):2074-2083. PubMed ID: 30099442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SOX17/miR-371-5p/SOX2 axis inhibits EMT, stem cell properties and metastasis in colorectal cancer.
    Li Y; Lv Z; He G; Wang J; Zhang X; Lu G; Ren X; Wang F; Zhu X; Ding Y; Liao W; Ding Y; Liang L
    Oncotarget; 2015 Apr; 6(11):9099-112. PubMed ID: 25868860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-802 inhibits the proliferation, invasion, and epithelial-mesenchymal transition of glioblastoma multiforme cells by directly targeting SIX4.
    Huang W; Shi Y; Han B; Wang Q; Zhang B; Qi C; Liu F
    Cell Biochem Funct; 2020 Jan; 38(1):66-76. PubMed ID: 31702057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2.
    Pang H; Zheng Y; Zhao Y; Xiu X; Wang J
    Biochem Biophys Res Commun; 2015 Dec; 468(4):739-45. PubMed ID: 26556542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of Cancer Metabolic SREBP1/miR-142-5p Suppresses Epithelial-Mesenchymal Transition and Stemness in Esophageal Carcinoma.
    Huang CM; Huang CS; Hsu TN; Huang MS; Fong IH; Lee WH; Liu SC
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861383
    [No Abstract]   [Full Text] [Related]  

  • 16. Specificity protein 1 expression contributes to Bcl-w-induced aggressiveness in glioblastoma multiforme.
    Lee WS; Kwon J; Yun DH; Lee YN; Woo EY; Park MJ; Lee JS; Han YH; Bae IH
    Mol Cells; 2014 Jan; 37(1):17-23. PubMed ID: 24552705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-7-5p suppresses stemness and enhances temozolomide sensitivity of drug-resistant glioblastoma cells by targeting Yin Yang 1.
    Jia B; Liu W; Gu J; Wang J; Lv W; Zhang W; Hao Q; Pang Z; Mu N; Zhang W; Guo Q
    Exp Cell Res; 2019 Feb; 375(1):73-81. PubMed ID: 30586549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-106a-5p facilitates human glioblastoma cell proliferation and invasion by targeting adenomatosis polyposis coli protein.
    Li D; Wang Z; Chen Z; Lin L; Wang Y; Sailike D; Luo K; Du G; Xiang X; Jiafu GD
    Biochem Biophys Res Commun; 2016 Dec; 481(3-4):245-250. PubMed ID: 27815074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-93-5p suppresses cellular senescence by directly targeting Bcl-w and p21.
    Choi JY; Shin HJ; Bae IH
    Biochem Biophys Res Commun; 2018 Nov; 505(4):1134-1140. PubMed ID: 30318121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated miR-671-5p / CDR1-AS / CDR1 / VSNL1 axis is involved in glioblastoma multiforme.
    Barbagallo D; Condorelli A; Ragusa M; Salito L; Sammito M; Banelli B; Caltabiano R; Barbagallo G; Zappalà A; Battaglia R; Cirnigliaro M; Lanzafame S; Vasquez E; Parenti R; Cicirata F; Di Pietro C; Romani M; Purrello M
    Oncotarget; 2016 Jan; 7(4):4746-59. PubMed ID: 26683098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.